Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Mann

Showing results (81-90 of 116) with videos related to

Pageof 12
Sort By:
ANZ Journal of Surgery|January 25, 2018
Uptake of adjuvant breast cancer treatments recommended by multi-disciplinary meetingsMelinda Pattanasri, Kenneth Elder, Carolyn Nickson, et al.
Annals of Surgical Oncology|May 3, 2018
Treatment Intensity Differences After Early-Stage Breast Cancer (ESBC) Diagnosis Depending on Participation in a Screening ProgramKenneth Elder, Carolyn Nickson, Melinda Pattanasri, et al.
Breast (Edinburgh, Scotland)|July 8, 2014
Assessing and managing breast cancer risk: clinicians' current practice and future needsIan M Collins, Emma Steel, G Bruce Mann, et al.
Asia-Pacific Journal of Clinical Oncology|August 7, 2015
Implementing novel models of posttreatment care for cancer survivors: Enablers, challenges and recommendationsMichael Jefford, Nicole Kinnane, Paula Howell, et al.
Cancer Cell|July 13, 2013
Targeting BCL-2 with the BH3 mimetic ABT-199 in estrogen receptor-positive breast cancerFrançois Vaillant, Delphine Merino, Lily Lee, et al.
BMJ Open|June 3, 2025
Consensus process to agree upon surgical quality assurance processes within a pragmatic, multicentre randomised clinical trial comparing targeted axillary dissection and axillary node clearance: the TADPOLE-TOGETHER projectShelley Potter, Ruth Mullan, Henry Cain, et al.
Cancers|December 10, 2021
Prognostic Risk Assessment and Prediction of Radiotherapy Benefit for Women with Ductal Carcinoma In Situ (DCIS) of the Breast, in a Randomized Clinical Trial (SweDCIS)Fredrik Wärnberg, Per Karlsson, Erik Holmberg, et al.
BJS Open|October 30, 2025
Safe and transparent introduction and evaluation of targeted axillary dissection in patients with node-positive breast cancer undergoing primary surgery: international consensus processShelley Potter, Ruth Mullan, Henry Cain, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 1, 2015
Copy number analysis of ductal carcinoma in situ with and without recurrenceKylie L Gorringe, Sally M Hunter, Jia-Min Pang, et al.
International Journal of Radiation Oncology, Biology, Physics|September 17, 2022
A Novel Biosignature Identifies Patients With DCIS With High Risk of Local Recurrence After Breast Conserving Surgery and Radiation TherapyFrank A Vicini, G Bruce Mann, Chirag Shah, et al.
Pageof 12

Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
ANZ Journal of Surgery|January 25, 2018
Uptake of adjuvant breast cancer treatments recommended by multi-disciplinary meetingsMelinda Pattanasri, Kenneth Elder, Carolyn Nickson, et al.
Annals of Surgical Oncology|May 3, 2018
Treatment Intensity Differences After Early-Stage Breast Cancer (ESBC) Diagnosis Depending on Participation in a Screening ProgramKenneth Elder, Carolyn Nickson, Melinda Pattanasri, et al.
Breast (Edinburgh, Scotland)|July 8, 2014
Assessing and managing breast cancer risk: clinicians' current practice and future needsIan M Collins, Emma Steel, G Bruce Mann, et al.
Asia-Pacific Journal of Clinical Oncology|August 7, 2015
Implementing novel models of posttreatment care for cancer survivors: Enablers, challenges and recommendationsMichael Jefford, Nicole Kinnane, Paula Howell, et al.
Cancer Cell|July 13, 2013
Targeting BCL-2 with the BH3 mimetic ABT-199 in estrogen receptor-positive breast cancerFrançois Vaillant, Delphine Merino, Lily Lee, et al.
BMJ Open|June 3, 2025
Consensus process to agree upon surgical quality assurance processes within a pragmatic, multicentre randomised clinical trial comparing targeted axillary dissection and axillary node clearance: the TADPOLE-TOGETHER projectShelley Potter, Ruth Mullan, Henry Cain, et al.
Cancers|December 10, 2021
Prognostic Risk Assessment and Prediction of Radiotherapy Benefit for Women with Ductal Carcinoma In Situ (DCIS) of the Breast, in a Randomized Clinical Trial (SweDCIS)Fredrik Wärnberg, Per Karlsson, Erik Holmberg, et al.
BJS Open|October 30, 2025
Safe and transparent introduction and evaluation of targeted axillary dissection in patients with node-positive breast cancer undergoing primary surgery: international consensus processShelley Potter, Ruth Mullan, Henry Cain, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 1, 2015
Copy number analysis of ductal carcinoma in situ with and without recurrenceKylie L Gorringe, Sally M Hunter, Jia-Min Pang, et al.
International Journal of Radiation Oncology, Biology, Physics|September 17, 2022
A Novel Biosignature Identifies Patients With DCIS With High Risk of Local Recurrence After Breast Conserving Surgery and Radiation TherapyFrank A Vicini, G Bruce Mann, Chirag Shah, et al.
Pageof 12